GHRH analog comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Last reviewed on 2026-06-08. Where a claim depends on a specific study, the study is described rather than over-claimed.
At the pituitary, the peptide binds the growth hormone-releasing hormone receptor on somatotroph cells. Receptor activation raises intracellular cyclic AMP and triggers release of stored growth hormone. Somatostatin and other hypothalamic signals modulate this response. Negative feedback from insulin-like growth factor 1 also influences output. The same regulatory architecture operates with the native hormone. Whether the synthetic analog alters feedback dynamics over repeated exposure remains an open question. Most published receptor work uses cell models rather than intact human systems.
CJC-1295 is a synthetic peptide belonging to the growth hormone-releasing hormone analog family. It comprises twenty-nine amino acid residues derived from the N-terminal region of natural GHRH. The molecule incorporates several non-natural substitutions that increase resistance to enzymatic degradation. These modifications extend its activity compared with the native hormone fragment. Researchers use it to study pituitary growth hormone secretion in laboratory and clinical settings. This compound is distinct from native GHRH in its stability profile.
Two principal forms appear in the literature and in research supply. One carries a drug affinity complex, a maleimide-based group that forms a covalent bond with circulating albumin. This linkage slows clearance and produces a long-lasting elevation of peptide levels. The other form lacks that group and is often labeled MOD GRF(1-29). It has a much shorter circulation time. Both variants retain the same core receptor-binding sequence. Reported half-lives differ substantially between the two.
The albumin-binding version stays in circulation for days, because covalent attachment to serum albumin shields the peptide from rapid filtration and degradation. Reported half-lives for this form fall in the range of several days. The version without the linker is cleared in minutes, with estimates often near thirty minutes in animal work. These figures come from small studies and vary with assay method, species, and route, so they are best read as approximate rather than fixed constants.
Studies in this area generally track growth hormone pulses, insulin-like growth factor 1 concentrations, and occasionally body composition endpoints. Most published human data come from early, small trials, and questions about long-term effects remain open. Whether repeated exposure alters pituitary responsiveness over time is not settled. Analytical work relies on immunoassays for the hormones and on mass spectrometry for the peptide itself, because the two measurements answer different questions.
| Property | Value | Notes |
|---|---|---|
| Molecular weight, DAC form | About 3647 Da | Varies with salt form |
| Molecular weight, non-DAC form | About 3358 Da | MOD GRF(1-29) |
| Solubility class | Water soluble | Also dissolves in polar solvents |
| Reported half-life, DAC form | About five to eight days | Values from human studies |
| Common synonyms | CJC-1295; MOD GRF(1-29) | Name depends on variant |
Rubidium (37Rb) has 35 known isotopes, from 72Rb to 106Rb, with naturally occurring rubidium composed of two: stable 85Rb (72.2%) and radioactive 87Rb (27.8%). The primordial radionuclide 87Rb has a half-life of 4.97×1010 years, beta decaying to stable 87Sr. It is, as the element is, widespread on Earth as rubidium readily substitutes for potassium in all minerals. The decay of 87Rb has been used extensively in dating rocks; see rubidium–strontium dating for a more detailed discussion. Other than 87Rb, the longest-lived radioisotopes are 83Rb with a half-life of 86.2 days, 84Rb with a half-life of 32.82 days, and 86Rb with a half-life of 18.645 days. All other radioisotopes have half-lives less than a day, most less than 20 minutes. Of the isomeric states the most stable is 82mRb at 6.472 hours. The ground state of 82Rb has a much shorter half-life of 1.2575 minutes. It is used medically in some cardiac positron emission tomography scans to assess myocardial perfusion. It is synthesized through the longer-lived 82Sr, made in a cyclotron, though a generator. It may be administered as the chloride.
== Adverse effects == In about 0.1% of cases people have had anaphylactic reactions to lixisenatide and in about 0.2% of cases the drug has caused pancreatitis. Use with insulin or sulfonylurea may cause hypoglycemia. In some cases, people with no kidney disease have had acute kidney injury and in some people with existing kidney disease the condition has gotten worse. Because lixisenatide is a peptide people can and do develop an immune response to it that will eventually make the drug ineffective; people who have developed antibodies to lixisenatide tend to have more inflammation at the injection site. At least 5% of people had nausea, vomiting, diarrhea, headache, or dizziness after taking lixisenatide.
In 2013, sources connected with Swedish intelligence told newspaper Svenska Dagbladet, that Sweden's National Defence Radio Establishment (FRA) predicted that there would be a war between Russia and Georgia before the United States did. One of the sources said: "We could see how the Russians moved military units and how things then became silent. That meant everything was in place and that the final preparations for a strike were underway. We knew that Russia would likely enter Georgia. At the same time, the US drew a different conclusion: that there would be no war."
skin wound healing and regeneration of other tissues such as bone (PDGF-BB) neutropenia myelodysplastic syndrome (MDS) leukemias aplastic anaemia bone marrow transplantation angiogenesis for cardiovascular diseases
Sources: en.wikipedia.org
=== Food storage === Xerophiles are a concern to food storage industry due to their ability to bypass common food preservation methods. Many foods are preserved by creating high osmotic pressures that dry out and kill any microbes that attempt to culture in the food. Foods such as honey or jam have such high levels of sugar and low levels of water normal micro organisms can not grow on them. However, xerophilic organisms can grow in these mediums posing a threat to food safety. The common food preservation methods of reducing water activity (food drying) may not always be sufficient to prevent the growth of xerophilic organisms, often resulting in food spoilage. Some mold and yeast species are xerophilic. Mold growth on bread is an example of food spoilage by xerophilic organisms. Complete dehydration based on the freeze-drying technique with effective protection inside a tight packaging system, strictly impervious to water and atmospheric gases (O2 and CO2), may be required for long-term preservation of food and pharmacochemical substances (antibiotics, vaccines...). Freeze drying can limit the microbial activity on the long term, as long as the product remains perfectly dry in a hermetically sealed and intact package, but it is not a sterilisation technique per se, because after rehydration, even if many dehydrated cells suffer irreversible and lethal damages, some resistant spores and bacterial endospores can still be revived again, and multiplied, by means of microbiological cultures if the product was not initially sterilized by applying a proven technique.
=== Modified insulin suppression test === Another measure of insulin resistance is the modified insulin suppression test developed by Gerald Reaven at Stanford University. The test correlates well with the euglycemic clamp, with less operator-dependent error. This test has been used to advance the large body of research relating to the metabolic syndrome. Patients initially receive 25 μg of octreotide (Sandostatin) in 5 mL of normal saline over 3 to 5 minutes via intravenous infusion (IV) as an initial bolus, and then, are infused continuously with an intravenous infusion of somatostatin (0.27 μg/m2/min) to suppress endogenous insulin and glucose secretion. Next, insulin and 20% glucose are infused at rates of 32 and 267 mg/m2/min, respectively. Blood glucose is checked at zero, 30, 60, 90, and 120 minutes, and thereafter, every 10 minutes for the last half-hour of the test. These last four values are averaged to determine the steady-state plasma glucose level (SSPG). Subjects with an SSPG greater than 150 mg/dL are considered to be insulin-resistant.
PLP forms an imine with the amino acid derivative, facilitating the breaking of the carbon–carbon bond and release of carbon dioxide. The protonation of the amine derived from tryptophan restores the aromaticity of the pyridine ring, leading to the production of 5-hydroxytryptamine and PLP. Serotonin N-acetyltransferase, with histidine residue His122, is hypothesized to deprotonate the primary amine of 5-hydroxytryptamine. This deprotonation allows the lone pair on the amine to attack acetyl-CoA, forming a tetrahedral intermediate. The thiol from coenzyme A then acts as a leaving group when attacked by a general base, producing N-acetylserotonin. The final step in the biosynthesis of melatonin involves the methylation of N-acetylserotonin at the hydroxyl position by SAM, resulting in the production of S-adenosyl homocysteine (SAH) and melatonin.
When a bioactive ligand with a known structure is to be screened against a protein with limited structural information, modeling is done with regard to ligand structure. Pharmacophore modeling identifies key electronic and structural features that are associated with therapeutic activity across similarly bioactive structural analogs, and accordingly requires large libraries with corresponding experimental data to enhance predictive power. Compound structures are superimposed virtually and common elements are scored on the basis of their tendency toward bioactivity. The move away from lock-and-key based modeling toward induced-fit based modeling has improved binding predictions but has also given rise to the challenge of modeling ligand flexibility, which requires building a database of conformational models and uses large amounts of data storage space. Another approach is the so-called on-the-fly method, in which conformational models are tested during the process of pharmacophore modeling, without a database; this method requires significantly less storage space at the cost of high computing time. A second challenge arises from the decision of how to superimpose analog structures. A common approach is to use a least-squares regression for superimposition, but this requires user-selected anchor points and therefore introduces human bias into the process. Pharmacophore models require training data sets, giving rise to another challenge—selection of the appropriate library of compounds to adequately train models.
=== Retro-Diels-Alder reaction === This reaction occurs mainly in cyclohexene and its derivatives. Upon ionization, the pi electrons are excited and generate a charge site and a radical site. Following this, two successive α cleavages yield a butadiene radical and a neutral ethene since ethene has a higher ionisation energy than butadiene ( Stevenson's rules).
Sources: en.wikipedia.org
It is a synthetic peptide modeled on growth hormone-releasing hormone. The molecule is used in research on pituitary growth hormone secretion. It differs from the natural hormone through several stabilizing substitutions.
The DAC form carries a maleimide group that binds albumin and extends circulation time. The non-DAC form lacks this group and clears much faster. Both share the same receptor-binding core.
It targets the growth hormone-releasing hormone receptor on pituitary somatotroph cells. Activation raises cyclic AMP and promotes growth hormone release. Normal feedback pathways remain part of the response.
Reported values cluster in the range of several days, reflecting slow release from the albumin complex. Estimates differ across species and assay platforms. The figure describes circulation time in study settings rather than a fixed property.